Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients

Severe negative syndrome may be related to a distinct lipid pathophysiology

S. F. Chen, T. M. Hu, T. H. Lan, H. J. Chiu, L. Y. Sheen, E. W. Loh

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Metabolic abnormality is common among schizophrenia patients. Some metabolic traits were found associated with subgroups of schizophrenia patients. Objectives: We examined a possible relationship between metabolic abnormality and psychosis profile in schizophrenia patients. Method: Three hundred and seventy-two chronic schizophrenia patients treated with antipsychotics for more than 2 years were assessed with the Positive and Negative Syndrome Scale. A set of metabolic traits was measured at scheduled checkpoints between October 2004 and September 2006. Results: Multiple regressions adjusted for sex showed negative correlations between body mass index (BMI) and total score and all subscales; triglycerides (TG) was negatively correlated with total score and negative syndrome, while HDLC was positively correlated with negative syndrome. When sex interaction was concerned, total score was negatively correlated with BMI but not with others; negative syndrome was negatively correlated with BMI and positively with HDLC. No metabolic traits were correlated with positive syndrome or general psychopathology. Conclusions: Loss of body weight is a serious health problem in schizophrenia patients with severe psychosis syndrome, especially the negative syndrome. Schizophrenia patients with severe negative syndrome may have a distinct lipid pathophysiology in comparison with those who were less severe in the domain.

Original languageEnglish
Pages (from-to)167-171
Number of pages5
JournalEuropean Psychiatry
Volume29
Issue number3
DOIs
Publication statusPublished - Mar 1 2014
Externally publishedYes

Fingerprint

Psychotic Disorders
Schizophrenia
Lipids
Body Mass Index
Psychopathology
Antipsychotic Agents
Triglycerides
Body Weight
Health

Keywords

  • Glucose
  • Lipid
  • Metabolism
  • Psychosis
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients : Severe negative syndrome may be related to a distinct lipid pathophysiology. / Chen, S. F.; Hu, T. M.; Lan, T. H.; Chiu, H. J.; Sheen, L. Y.; Loh, E. W.

In: European Psychiatry, Vol. 29, No. 3, 01.03.2014, p. 167-171.

Research output: Contribution to journalArticle

@article{a2689712d9984a168aa0a0acc0b1e181,
title = "Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: Severe negative syndrome may be related to a distinct lipid pathophysiology",
abstract = "Background: Metabolic abnormality is common among schizophrenia patients. Some metabolic traits were found associated with subgroups of schizophrenia patients. Objectives: We examined a possible relationship between metabolic abnormality and psychosis profile in schizophrenia patients. Method: Three hundred and seventy-two chronic schizophrenia patients treated with antipsychotics for more than 2 years were assessed with the Positive and Negative Syndrome Scale. A set of metabolic traits was measured at scheduled checkpoints between October 2004 and September 2006. Results: Multiple regressions adjusted for sex showed negative correlations between body mass index (BMI) and total score and all subscales; triglycerides (TG) was negatively correlated with total score and negative syndrome, while HDLC was positively correlated with negative syndrome. When sex interaction was concerned, total score was negatively correlated with BMI but not with others; negative syndrome was negatively correlated with BMI and positively with HDLC. No metabolic traits were correlated with positive syndrome or general psychopathology. Conclusions: Loss of body weight is a serious health problem in schizophrenia patients with severe psychosis syndrome, especially the negative syndrome. Schizophrenia patients with severe negative syndrome may have a distinct lipid pathophysiology in comparison with those who were less severe in the domain.",
keywords = "Glucose, Lipid, Metabolism, Psychosis, Schizophrenia",
author = "Chen, {S. F.} and Hu, {T. M.} and Lan, {T. H.} and Chiu, {H. J.} and Sheen, {L. Y.} and Loh, {E. W.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1016/j.eurpsy.2013.04.003",
language = "English",
volume = "29",
pages = "167--171",
journal = "European Psychiatry",
issn = "0924-9338",
publisher = "Elsevier Masson",
number = "3",

}

TY - JOUR

T1 - Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients

T2 - Severe negative syndrome may be related to a distinct lipid pathophysiology

AU - Chen, S. F.

AU - Hu, T. M.

AU - Lan, T. H.

AU - Chiu, H. J.

AU - Sheen, L. Y.

AU - Loh, E. W.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Background: Metabolic abnormality is common among schizophrenia patients. Some metabolic traits were found associated with subgroups of schizophrenia patients. Objectives: We examined a possible relationship between metabolic abnormality and psychosis profile in schizophrenia patients. Method: Three hundred and seventy-two chronic schizophrenia patients treated with antipsychotics for more than 2 years were assessed with the Positive and Negative Syndrome Scale. A set of metabolic traits was measured at scheduled checkpoints between October 2004 and September 2006. Results: Multiple regressions adjusted for sex showed negative correlations between body mass index (BMI) and total score and all subscales; triglycerides (TG) was negatively correlated with total score and negative syndrome, while HDLC was positively correlated with negative syndrome. When sex interaction was concerned, total score was negatively correlated with BMI but not with others; negative syndrome was negatively correlated with BMI and positively with HDLC. No metabolic traits were correlated with positive syndrome or general psychopathology. Conclusions: Loss of body weight is a serious health problem in schizophrenia patients with severe psychosis syndrome, especially the negative syndrome. Schizophrenia patients with severe negative syndrome may have a distinct lipid pathophysiology in comparison with those who were less severe in the domain.

AB - Background: Metabolic abnormality is common among schizophrenia patients. Some metabolic traits were found associated with subgroups of schizophrenia patients. Objectives: We examined a possible relationship between metabolic abnormality and psychosis profile in schizophrenia patients. Method: Three hundred and seventy-two chronic schizophrenia patients treated with antipsychotics for more than 2 years were assessed with the Positive and Negative Syndrome Scale. A set of metabolic traits was measured at scheduled checkpoints between October 2004 and September 2006. Results: Multiple regressions adjusted for sex showed negative correlations between body mass index (BMI) and total score and all subscales; triglycerides (TG) was negatively correlated with total score and negative syndrome, while HDLC was positively correlated with negative syndrome. When sex interaction was concerned, total score was negatively correlated with BMI but not with others; negative syndrome was negatively correlated with BMI and positively with HDLC. No metabolic traits were correlated with positive syndrome or general psychopathology. Conclusions: Loss of body weight is a serious health problem in schizophrenia patients with severe psychosis syndrome, especially the negative syndrome. Schizophrenia patients with severe negative syndrome may have a distinct lipid pathophysiology in comparison with those who were less severe in the domain.

KW - Glucose

KW - Lipid

KW - Metabolism

KW - Psychosis

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84896731899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896731899&partnerID=8YFLogxK

U2 - 10.1016/j.eurpsy.2013.04.003

DO - 10.1016/j.eurpsy.2013.04.003

M3 - Article

VL - 29

SP - 167

EP - 171

JO - European Psychiatry

JF - European Psychiatry

SN - 0924-9338

IS - 3

ER -